Screener
Capricor Therapeutics CAPR Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| Line item | March 31, 2026 / (unaudited) | December 31, 2025 | December 31, 2025 |
|---|---|---|---|
| Lease liabilities, current | 841,135 | 202,376 | |
| CIRM liability, current | 6,339,862 | 6,421,984 | |
| Deferred revenue, current | 12,000,000 | 12,000,000 | |
| TOTAL CURRENT LIABILITIES | 33,637,289 | 35,836,760 | |
| LONG-TERM LIABILITIES | |||
| Lease liabilities, net of current | 13,943,595 | 14,320,389 | |
| TOTAL LONG-TERM LIABILITIES | 13,943,595 | 14,320,389 | |
| TOTAL LIABILITIES | 47,580,884 | 50,157,149 |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's total current liabilities?
- Capricor Therapeutics (CAPR) reported total current liabilities of $33.64M in Q1 2026.
- How has Capricor Therapeutics's total current liabilities changed year-over-year?
- Capricor Therapeutics's total current liabilities increased by 50.6% year-over-year, from $22.34M to $33.64M.
- What is the long-term trend for Capricor Therapeutics's total current liabilities?
- Over 5 years (2020 to 2025), Capricor Therapeutics's total current liabilities has grown at a 64.5% compound annual growth rate (CAGR), from $2.97M to $35.84M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Capricor Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude